Bespoke Corporate Advisory, Capital Raising and Investor Relations solutions for emerging Australian companies
About us
Candour Advisory provide Equity Capital Market, Corporate Advisory and Investor Relations services to a variety of companies, including but not limited to the following sectors:
-
Life Sciences (Diagnostics, Bio-technology, Medical Device & Healthcare)
-
Technology (Emerging/Mobile)
-
Industrial (including Specialty Chemicals)
-
Resources, and
-
Agriculture
Corporate Advisory
-
Merger, acquisition and divestment advice
-
Advice on strategic investments and joint venture transactions
-
Capital restructuring and shareholder wealth creation and protection
-
Negotiating and managing commercial and corporate transactions
-
Advice on financing alternatives including equity, debt & hybrid forms of security
-
Advice on sourcing & selection of Strategic Partners/Investors
Capital and Debt Raisings & Initial Public Offerings
-
Sourcing and providing various forms of expansion capital
-
Management of IPOs on behalf of issuers
-
Management of capital raising activities for listed/unlisted companies
-
Identifying & liaising with Institutions/Equity Partners
Investor Relations
-
Assisting boards and management with how they communicate and interact with the investment and corporate community
-
Developing, implementing and executing an appropriate investor relations strategy and programme
-
Clearly communicating a company’s investment case and key messages
-
Assistance with the design and implementation of a digital IR strategy
Private Family Office & High Net Worth advisory services
-
Investment/Opportunity identification
-
Analysis/valuation of opportunities
-
Advice on transaction structuring or asset disposals
-
Assistance in negotiations with third parties